| Agility Becomes First U.S. Publicly Listed Pure-Play Humanoid Robotics Company, Begins Trading Today on Nasdaq as AGLT |
Globe Newswire |
11/05 |
07:00 |
| EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 |
Globe Newswire |
11/05 |
07:00 |
| Nurix Therapeutics to Present New and Updated Data from Ongoing Phase 1a/1b Trial of Bexobrutideg (NX-5948) in Relapsed/Refractory CLL/SLL at the 68th ASH Annual Meeting and Exposition |
Globe Newswire |
11/05 |
07:00 |
| Peloton Announces Q1 FY2027 Financial Results |
Globe Newswire |
11/05 |
07:00 |
| C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights |
Globe Newswire |
11/05 |
07:00 |
| GPGI Reports Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Malibu Boats, Inc. Announces Results for the Three Months Ended September 30, 2026 |
Globe Newswire |
11/05 |
07:00 |
| KVH Industries Reports Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Xunlei Limited Schedules 2026 Unaudited Third Quarter Earnings Release on November 12, 2026 |
Globe Newswire |
11/05 |
07:00 |
| Monte Rosa Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
11/05 |
07:00 |
| Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/05 |
07:00 |
| Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO) |
Globe Newswire |
11/05 |
07:00 |
| Entrada Therapeutics Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
07:00 |
| Tenax Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/05 |
07:00 |
| Astec Reports Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Perma-Fix Reports Third Quarter 2026 Results, with Sequential Growth of 39% in Revenue and 25% in Treatment Backlog from Second Quarter 2026 |
Globe Newswire |
11/05 |
07:00 |
| Akebia Therapeutics Reports Positive Topline Data from VOCAL Trial Showing Vadadustat Dosed TIW Met Primary Endpoint of Non-Inferiority to ESA in Maintaining Hemoglobin |
Globe Newswire |
11/05 |
07:00 |
| Weight Watchers Announces Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Commerce Announces Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
07:00 |
| illumin Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
07:00 |
| Beamr Featured in The Wall Street Transcript; Expects Approximately 50% Revenue Growth in 2026 |
Globe Newswire |
11/05 |
07:00 |
| Apyx Medical Corporation Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
07:00 |
| Opus Genetics Completes Dosing in Cohort 2 of Phase 1/2 Clinical Trial of OPGx-BEST1 Gene Therapy for Inherited Retinal Diseases |
Globe Newswire |
11/05 |
07:00 |
| iMDx to Release Third Quarter Results on November 16, 2026 |
Globe Newswire |
11/05 |
07:00 |
| Aclaris Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate and Clinical Update |
Globe Newswire |
11/05 |
06:59 |
